Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Avacta (AVCT)

Avacta Group Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AVCT
DateTimeSourceHeadlineSymbolCompany
01/05/202411:53Alliance NewsAlliance NewsIN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEOLSE:AVCTAvacta Group Plc
30/04/202416:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:AVCTAvacta Group Plc
30/04/202407:01RNS Regulatory NewsAvacta Group PLC Full Year ResultsLSE:AVCTAvacta Group Plc
30/04/202407:00RNS Regulatory NewsAvacta Group PLC Board ChangeLSE:AVCTAvacta Group Plc
26/04/202409:51RNS Regulatory NewsAvacta Group PLC Block listing Interim Return REPLACEMENTLSE:AVCTAvacta Group Plc
26/04/202407:00RNS Regulatory NewsAvacta Group PLC Block Listing Six Monthly ReturnLSE:AVCTAvacta Group Plc
23/04/202409:43RNS Regulatory NewsAvacta Group PLC Block Listing Application to AIMLSE:AVCTAvacta Group Plc
23/04/202407:00RNS Regulatory NewsAvacta Group PLC Notice of ResultsLSE:AVCTAvacta Group Plc
22/04/202417:51Alliance NewsAlliance NewsTRADING UPDATES: First Tin updates Tellerhauser estimatesLSE:AVCTAvacta Group Plc
22/04/202412:14RNS Regulatory NewsAvacta Group PLC Issue of Equity and Total Voting RightsLSE:AVCTAvacta Group Plc
09/04/202417:00RNS Regulatory NewsAvacta Group PLC Avacta Reports Data at the AACR Annual MeetingLSE:AVCTAvacta Group Plc
08/04/202407:00RNS Regulatory NewsAvacta Group PLC AVA6000 Abstract Release by AACRLSE:AVCTAvacta Group Plc
05/04/202421:30UK RegulatoryAvacta Group - AVA6000 Abstract Release by AACR and Full Presentation UpdateLSE:AVCTAvacta Group Plc
28/03/202416:00RNS Non-RegulatoryAvacta Group PLC Investor WebinarLSE:AVCTAvacta Group Plc
21/03/202410:37Alliance NewsAlliance NewsAvacta doses third patient in drug conjugate trial for tumour tissueLSE:AVCTAvacta Group Plc
21/03/202407:00RNS Regulatory NewsAvacta Group PLC Update on AVA6000 Phase 1a Clinical Trial ProgressLSE:AVCTAvacta Group Plc
18/03/202414:31Alliance NewsAlliance NewsIN BRIEF: Avacta shareholders give AGM go-ahead to issue new sharesLSE:AVCTAvacta Group Plc
18/03/202413:26RNS Regulatory NewsAvacta Group PLC Result of General MeetingLSE:AVCTAvacta Group Plc
06/03/202407:00RNS Regulatory NewsAvacta Group PLC Avacta Announces AVA6000 Poster at AACRLSE:AVCTAvacta Group Plc
05/03/202421:30UK RegulatoryUpdated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024LSE:AVCTAvacta Group Plc
05/03/202417:09Alliance NewsAlliance NewsEARNINGS AND TRADING: Harland & Wolff wins major Falklands contractLSE:AVCTAvacta Group Plc
05/03/202407:00RNS Regulatory NewsAvacta Group PLC Result of REX Retail OfferLSE:AVCTAvacta Group Plc
29/02/202412:18Alliance NewsAlliance NewsAvacta increases placing size to GBP26 million thanks to strong demandLSE:AVCTAvacta Group Plc
29/02/202407:00RNS Regulatory NewsAvacta Group PLC Result of PlacingLSE:AVCTAvacta Group Plc
28/02/202420:31Alliance NewsAlliance NewsTRADING UPDATES: Avacta plans fundraise to fund clinical developmentLSE:AVCTAvacta Group Plc
28/02/202416:42RNS Regulatory NewsAvacta Group PLC Proposed REX Retail OfferLSE:AVCTAvacta Group Plc
28/02/202416:41RNS Regulatory NewsAvacta Group PLC Proposed Fundraise to progress TherapeuticsLSE:AVCTAvacta Group Plc
16/02/202407:00RNS Regulatory NewsAvacta Group PLC Share Incentive Plan/Issue of EquityLSE:AVCTAvacta Group Plc
22/01/202410:51UK RegulatoryAvacta Group PLC Issue of Equity and Total Voting RightsLSE:AVCTAvacta Group Plc
19/01/202409:11Alliance NewsAlliance NewsIN BRIEF: Avacta says new head of R&D Coughlin brings "deep expertise"LSE:AVCTAvacta Group Plc
 Showing the most relevant articles for your search:LSE:AVCT